Yakira Capital Management’s Cidara Therapeutics CDTX Stock Holding History

Yakira Capital Management’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-7,337	Closed	-$1.62M	–	204
2025 Q4	$1.62M	Buy	+7,337	New	+$1.19M	0.55%	44

Yakira Capital Management's CDTX Position: Q1 2026 in Review

Yakira Capital Management sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 7,337 shares — an estimated $1.62M sold.

Yakira Capital Management first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $1.62M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Yakira Capital Management reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Yakira Capital Management sold 7,337 Cidara Therapeutics shares in Q1 2026, an estimated $1.62M.
Yakira Capital Management first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
Yakira Capital Management's Cidara Therapeutics position peaked at $1.62M in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Yakira Capital Management's 13F filing for Q1 2026, filed 14 May 2026.